Aligos Therapeutics (ALGS) EPS (Weighted Average and Diluted) (2021 - 2025)
Historic EPS (Weighted Average and Diluted) for Aligos Therapeutics (ALGS) over the last 5 years, with Q3 2025 value amounting to -$3.04.
- Aligos Therapeutics' EPS (Weighted Average and Diluted) rose 97.72% to -$3.04 in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.78, marking a year-over-year decrease of 16550.34%. This contributed to the annual value of -$20.94 for FY2024, which is 3875.79% up from last year.
- Latest data reveals that Aligos Therapeutics reported EPS (Weighted Average and Diluted) of -$3.04 as of Q3 2025, which was up 97.72% from -$1.53 recorded in Q2 2025.
- In the past 5 years, Aligos Therapeutics' EPS (Weighted Average and Diluted) ranged from a high of $0.81 in Q2 2024 and a low of -$13.11 during Q4 2024
- For the 5-year period, Aligos Therapeutics' EPS (Weighted Average and Diluted) averaged around -$2.6, with its median value being -$0.81 (2022).
- Examining YoY changes over the last 5 years, Aligos Therapeutics' EPS (Weighted Average and Diluted) showed a top increase of 28837.21% in 2024 and a maximum decrease of 346239.54% in 2024.
- Quarter analysis of 5 years shows Aligos Therapeutics' EPS (Weighted Average and Diluted) stood at -$0.78 in 2021, then surged by 34.62% to -$0.51 in 2022, then surged by 176.47% to $0.39 in 2023, then crashed by 3462.4% to -$13.11 in 2024, then skyrocketed by 76.82% to -$3.04 in 2025.
- Its last three reported values are -$3.04 in Q3 2025, -$1.53 for Q2 2025, and -$2.11 during Q1 2025.